to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
For more than 20 years, filmmaker, music producer, and creative visionary QD3 has been producing hits and influencing culture. QD3 was born in London and raised in Stockholm, Sweden where he got his start in Hip Hop by
touring as a break-dancer. With many gold, platinum and multi-platinum albums and singles to his name, QD3's success spreads to Rap, R&B and Pop. In addition to his many hits with artists such as Tupac, Ice Cube, and L.L. Cool J, he
has composed award-winning musical scores for film and TV projects such as Menace II Society, Fresh Prince of Bel Air, and Training Day. In 1999, QD3 started a documentary production
company, QD3 Entertainment, focused on chronicling the many dimensions of urban culture, garnering both commercial success and critical acclaim for titles such as the multi-platinum selling Tupac Shakur biopic, Thug
Angel; the BEEF series; and most recently, the Lil' Wayne (Sundance) biopic, The Carter. In June 2006, QD3 went on to form QD3 Digital to take advantage of the technology explosion of broadband video, user
generated content, video on demand, and mobile platforms. In 2009, QD3 Digital will be launching two web-based entertainment properties, qd3.com and ehustle.com. Early 2010 will follow with the launch of its first XBox and PS3 video game,
Scratch: The Ultimate DJ, in partnership with Genius Products, Numark, and Akai.
Jeff Hawkins is the Founder of Numenta, but he is also well known as the co-founder of two companies, Palm and Handspring, and as the architect of many computing products, such as the PalmPilot and the Treo smartphone.
Throughout his life Hawkins has also had a deep interest in neuroscience and theories of the neocortex. His interest in the brain led him to create the non-profit Redwood Neuroscience Institute (RNI), a scientific organization focused on
understanding how the human neocortex processes information. While at RNI, Hawkins developed a theory of neocortex which appeared in his 2004 book, On Intelligence. Along with Dileep George and Donna Dubinsky, Hawkins
founded Numenta in 2005 to develop a technology platform derived from his theory. It is his hope that Numenta will play a catalytic role in creating an industry based on this theory and technology. Jeff Hawkins earned his B.S. in
electrical engineering from Cornell University in 1979. He was elected to the National Academy of Engineering in 2003.
Dr. Ringold was most recently CEO of the Glaxo-Wellcome Group's Affymax Research Institute, where he managed the development of novel technologies to accelerate the pace of drug discovery. He is a co-founder and director
of Maxygen Corporation, a Managing Partner of Technogen Associates, L.P., a private investment firm, and has over fifteen years of experience managing the discovery and development of pharmaceuticals and novel, enabling life science
technologies. Prior to Affymax, Dr. Ringold served as Director and Vice President of the Institute for Cancer and Developmental Biology at Syntex, now a division of Hoffman La-Roche. Dr. Ringold received his B.A. in Biology from UC Santa
Cruz, and his Ph.D. in Microbiology from UC San Francisco. He was on the faculty of the Department of Pharmacology at the Stanford University School of Medicine, and is currently a consulting professor there.
Shai Agassi was a member of the Executive Board of SAP AG until March 31, 2007. He is responsible for the global development efforts for all SAP products and SAP's portfolio of industry-specific solutions. Before his
appointment to the SAP Executive Board, Agassi was CEO of SAP Portals and later of the combined company SAP Markets and SAP Portals, which previously operated as a fully owned subsidiary of SAP AG. The subsidiaries were integrated into SAP
in April 2002, at which point Agassi was appointed to the Board. A software entrepreneur, Agassi founded TopTier Software (originally called Quicksoft Development) in Israel in 1992 and later moved the company's headquarters to California.
He served the company in various capacities, including as chairman, chief technology officer, and then CEO. He managed the strategic plan, technical direction, and relationships with companies such as Baan, SAP, and Microsoft. TopTier was
a leading enterprise portal vendor when SAP acquired the company in April 2001. In addition to TopTier Software, Agassi co-founded several other companies with his father, Reuven Agassi, including Quicksoft Ltd., a leading multimedia
software localization and distribution company in the Israeli market; TopManage, a developer of small business software that was also acquired by SAP in April 2002 (which became SAP Business One, the small business offering by SAP); and
Quicksoft Media, a multimedia production company that ceased operations in 1995. Agassi graduated with honors from Technion, the Israel Institute of Technology, where he received a bachelor's degree in computer science. He is based at SAP
Labs United States in Palo Alto, California.
Anand Chandrasekaran brings a unique background that combines deep expertise and operating skills in mobile applications, consumer media and enterprise software. In 2001, he co- founded Aeroprise Inc. the world's most
deployed mobility software for Service Management. Anand wrote the original business plan, helped architect and launch the award-winning Aeroprise product suite and ran marketing/inside sales through bootstrapped and VC-funded phases to
build the company into a leader in enterprise mobility. Aeroprise customers include the Dept. of Homeland Security, theHartford, IBM, Bureau of A.T.F., Safeway, U.S. Air Force, Harvard University and DirecTV. He was on the Aeroprise Board
between 2001-2006 and an advisor to the Mobile Enterprise Alliance (MEA), an industry-forum promoting mobility standards amongst enterprises which included over 1000 member organizations.
As the president of Yahoo! Inc., Susan L. Decker is a key participant in determining Yahoo!'s business strategy and vision. She is responsible for all of the global business operations of Yahoo!, including sales, product
marketing, and distribution across the three major customer groups of audience, advertisers, and publishers. Prior to that, from December 2006 - June 2007, she served as the head of one of Yahoo!'s two major business units, the Advertiser
and Publisher Group (APG). In that role, she was instrumental in developing the company's recent reorganization plan and strategy to transform how advertisers connect with their target customers online. Preceding her work with APG, Decker
was Executive Vice President and Chief Financial Officer for seven years, managing all aspects of the company's financial and administrative direction within key functional areas, including finance, facilities, investor relations (and
human resources and legal through December 2006). Decker served on the board of directors of Pixar Animation Studios from June 2004 to May 2006 until its sale to Disney, and currently serves on the board of directors for Berkshire
Hathaway, Intel Corporation, and Costco Wholesale. She holds a Bachelor of Science degree from Tufts University, with a double major in computer science and economics, and an MBA from Harvard Business School.
Dr. Larry Brilliant is the Executive Director of Google.org, where he leads major initiatives aimed at reducing global poverty, improving the health of the least advantaged in the world, and working to halt the effects
of the climate crisis. Larry is an M.D. and M.P.H., board-certified in preventive medicine and public health. He is a founder and director of The Seva Foundation, which works in dozens of countries around the world, primarily to eliminate
preventable and curable blindness. He serves as a member of the strategic advisory committee for Kleiner Perkins (KPCB) Venture Capital and also sits on the boards of The Skoll Foundation, Health Metrics Network, Omidyar Networks Humanity
United, and InSTEDD, an organization bringing technological tools to improve disaster response. In addition to his medical career, Larry co-founded The Well, a pioneering virtual community, with Stewart Brand in 1985. He also holds a
telecommunications technology patent and has served as CEO of two public companies and other venture-backed start-ups. The author of two books and dozens of articles on infectious diseases, blindness, and international health policy, Larry
has worked at every level of government. He was recently a "first responder" for CDC's smallpox bio-terrorism response effort, volunteered in Sri Lanka for tsunami relief, and established an interdisciplinary consultancy to prepare for
possible pandemic influenza. Larry lived in India working as a United Nations medical officer for more than a decade where he played a key role in the successful World Health Organization (WHO) smallpox eradication program and has recently
worked for the WHO polio eradication effort as well. He was Associate Professor of epidemiology, global health planning and economic development at the University of Michigan. Larry earned a Masters in Public Health in health planning and
economic development from the Univ
John G. Melo is the Chief Executive Officer of Amyris Biotechnologies, a synthetic biology company working to reduce the cost of curing malaria and producing lower carbon, second generation bio-fuels. He was previously
president of U.S. Fuels for BP, where he led one of the world's largest petroleum marketing, logistics, and trading businesses. While in this role he successfully grew revenues from $25 billion to $34 billion and increased net cash by $1
billion. During this time his team developed one of the world's most successful ethanol blending and marketing businesses. He also worked on the development of BP's "Helios" re-branding. Prior to his eight years with BP, Mr. Melo was a
director with Ernst & Young in San Jose, California, and a management team member for several Northern California start-ups, including Computer Aided Services and Alldata Corporation. John serves on the Board of Directors for U.S. Oil,
a $1.6 billion energy company, and Cilion, a leading low-cost ethanol manufacturer. John is a member of the Economic Club of Chicago, The Chicago Club, The Chicago Council on Global Affairs, and YPO. He enjoys visiting his home country of
Azores, Portugal, as well as skiing, biking, tennis, golf, and time with his children.
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer,
psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These
products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global
Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health
economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and
Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa;
and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a
member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
KATHLEEN M. EISENHARDT is Professor of Strategy and Organization at Stanford University. She is widely known for her work on strategy, strategic decision making, and innovation in rapidly changing and highly competitive
markets. She is the coauthor (with Shona L. Brown) of the book Competing on the Edge: Strategy as Structured Chaos, published by Harvard Business School Press. Using analogies from The Grateful Dead to the Tour de France and scientific
underpinnings from complexity and time-paced evolutionary theories, this book describes how to compete successfully in dynamic markets. Professor Eisenhardt's current research centers on collaboration and competition in the converging
computing, telecommunications, and semiconductor industries, from the perspectives of complexity, evolutionary and game theories. For her past research on fast strategic decision making, she won the Pacific Telesis Foundation Award. She
has also received the Whittemore Prize (with D. Charles Galunic) for her writing on organizing global corporations in high velocity markets, and the Stern Award (with Claudia B. Schoonhoven) for her work on the formation of strategic
alliances in entrepreneurial companies. She was Co-Principal Investigator on the Global Electronics Study for Andersen Consulting. At Stanford, Professor Eisenhardt has received several teaching awards including selection as one of the Top
8 Professors at Stanford and her course has been selected by students as one of the top 10 at the University. She also serves as the Associate Director of the Stanford Computer Industry Project (SCIP). Professor Eisenhardt has consulted
for a number of major corporations on topics surrounding strategy and organization in rapidly changing markets with particular emphasis on strategy, strategic decision making, product innovation, creation of cross-business synergies, and
top management team dynamics. Her clients h
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.